168 related articles for article (PubMed ID: 30573917)
1. Burned-out Prostate Cancer ? Primary Metastatic Cancer Not Detected on Repeat Biopsy.
Mitsui Y; Sadahira T; Maruyama Y; Wada K; Tanimoto R; Sugimoto M; Araki M; Watanabe M; Yanai H; Watanabe T; Nasu Y
Acta Med Okayama; 2018 Dec; 72(6):605-609. PubMed ID: 30573917
[TBL] [Abstract][Full Text] [Related]
2. HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin.
Varinot J; Furudoï A; Drouin S; Phe V; Penna RR; Roupret M; Bitker MO; Cussenot O; Compérat E
Virchows Arch; 2016 May; 468(5):619-22. PubMed ID: 26931741
[TBL] [Abstract][Full Text] [Related]
3. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Murray SK; Breau RH; Guha AK; Gupta R
Am J Surg Pathol; 2004 Sep; 28(9):1154-62. PubMed ID: 15316314
[TBL] [Abstract][Full Text] [Related]
4. [A case of prostate cancer diagnosed pathologically by bone metastatic site biopsy].
Nakata S; Nakano K; Takahashi H; Shimizu K; Higashi H; Ohki K
Nihon Hinyokika Gakkai Zasshi; 2005 May; 96(4):507-10. PubMed ID: 15948412
[TBL] [Abstract][Full Text] [Related]
5. Detecting metastatic prostate carcinoma in pelvic lymph nodes following neoadjuvant hormone therapy: the eyes have it!
Kehr E; Masry P; Lis R; Loda M; Taplin ME; Hirsch MS
Histopathology; 2016 Jan; 68(2):303-7. PubMed ID: 26018610
[TBL] [Abstract][Full Text] [Related]
6. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Prostate Cancer Presenting With Bilateral Inguinal Lymphadenopathy.
Elsaqa M; Sharafeldeen M; Elabbady A
Clin Genitourin Cancer; 2019 Dec; 17(6):e1185-e1187. PubMed ID: 31522996
[No Abstract] [Full Text] [Related]
8. Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an important pitfall.
Lobo J; Tenace NP; Cañete-Portillo S; Carneiro I; Henrique R; Lucianò R; Harik LR; Magi-Galluzzi C
Histopathology; 2024 Feb; 84(3):507-514. PubMed ID: 37965687
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
[TBL] [Abstract][Full Text] [Related]
10. [A case of prostatic adenocarcinoma clinically presenting as supraclavicular and mediastinal lymphadenopathy].
Tsujino K; Sasada S; Kawahara K; Terada H; Komori C; Suzuki H; Okamoto N; Kobayashi M; Hirashima T; Matsui K; Kawase I
Nihon Kokyuki Gakkai Zasshi; 2007 Aug; 45(8):648-53. PubMed ID: 17763696
[TBL] [Abstract][Full Text] [Related]
11. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration biopsy diagnosis of metastatic prostate carcinoma to inguinal lymph node.
Rosa M; Chopra HK; Sahoo S
Diagn Cytopathol; 2007 Sep; 35(9):565-7. PubMed ID: 17703448
[TBL] [Abstract][Full Text] [Related]
13. [Metastatic lymph node collision of a prostatic adenocarcinoma and an urothelial carcinoma and review of the literature].
Junca A; Frouin E; Irani J; Fromont G; Levillain P
Ann Pathol; 2015 Dec; 35(6):496-501. PubMed ID: 26597142
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'.
Zhou M; Magi-Galluzzi C
Pathology; 2010 Jun; 42(4):334-8. PubMed ID: 20438405
[TBL] [Abstract][Full Text] [Related]
15. SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development.
Huang KC; Bégin LR; Palanisamy N; Donnelly B; Bismar TA
Urol Oncol; 2016 May; 34(5):235.e1-10. PubMed ID: 26725250
[TBL] [Abstract][Full Text] [Related]
16. Skin metastasis, an uncommon course of prostate carcinoma: a report of two cases.
Telis L; Wolf V; Yaskiv O; Pearson BJ; Katsigeorgis M; Jazayeri SB; Samadi DB; Unger PD
Malays J Pathol; 2016 Aug; 38(2):165-8. PubMed ID: 27568675
[TBL] [Abstract][Full Text] [Related]
17. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
[TBL] [Abstract][Full Text] [Related]
18. [Does PSA of less than 20 ng/ml exclude the diagnosis of metastatic prostate cancer?].
Amsellem D; Ogiez N; Salomon L; Chopin D; Abbou CC; Colombel M
Prog Urol; 1998 Dec; 8(6):1018-21. PubMed ID: 9894261
[TBL] [Abstract][Full Text] [Related]
19. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment.
Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM
Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pathologic features of prostate cancer detected after repeat false-negative biopsy in a screening population.
Steiner H; Moser P; Hager M; Berger AP; Klocker H; Spranger R; Rogatsch H; Bartsch G; Horninger W
Prostate; 2004 Feb; 58(3):277-82. PubMed ID: 14743467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
